MDA, MDEA and MBDB are synthetic amphetamine derivatives and closely related to the better-known MDMA . They belong to the group of empathogens.
MDA (3,4-methylenedioxyamphetamine, also 1-[1-3-benzodioxol-5-yl]-2-proponamine is a synthetic amphetamine derivative; together with MDMA, it occasionally occurs in MDMA pills, less frequently in pure form.
MDEA (3,4-methylenedioxyethylamphetamine) is a synthetic amphetamine derivative that rarely occurs with MDMA in pills.
MBDB (N-methyl-1-2-butanamine) is a synthetic amphetamine derivative.
These three substances are closely related to MDMA. They differ from MDMA and from each other primarily in how well one's own feelings are perceived (entactogenic effect), the degree of empathic understanding (empathic effect), and hallucinogenic effects.
Onset of action
MDA: after 30-45 minutes
MDEA: after 30-45 minutes
MBDB: after 30-60 minutes
Duration of action
MDA: 8 - 12 hours
MDEA: 4 - 6 hours
MBDB: 4 - 5 hours
MDA 1.3 mg per kg body weight (1.3 mg x 80 kg = 100 mg)
MDEA 1.3 mg per kg body weight (1.3 mg x 80 kg = 100 mg)
MBDB 1.5 mg per kg body weight (1.5 mg x 80 kg = 120 mg)
Nausea to nausea, dry mouth, cramping of the jaw muscles, sweating, coordination disorders, sleep disorders and trembling.
Long-term risks
MDA is both neurotoxic (damaging to the nerves) and hepatotoxic (damaging to the liver), and regular use can lead to schizophrenia-like symptoms.
Little is known about the risks of mixed use of the individual substances. Nevertheless, the same rules probably apply as for MDMA.
Avoid mixed use with other substances, especially:
LSD analogues are substances that are chemically very similar to LSD and can have comparable effects. Some of them have been known for a long time (e.g. ALD52, ETH-LAD, AL-LAD, PRO-LAD etc.) and have been studied pharmacologically as well as psychopharmacologically, at least in part. Others are newer "creations" (e.g. the derivatives 1P-LSD,1B-LSD, 1cP-LSD, 1V-LSDetc.), for which only few or no data are available. Certain LSD analogues can (still) be legally produced, traded and consumed in some countries, which is the main reason for their distribution.
Most LSD analogues are naturally different from LSD in their effect and/or potency (e.g. ETH-LAD, AL-LAD, LSZ etc.). In contrast, the so-called 1-acylated LSD compounds (e.g. 1P-LSD, 1V-LSD, 1B-LSD, ALD-52, etc.) are presumed, on the basis of pharmacological studies, to convert into LSD in the body (they function as so-called prodrugs) and thus have a comparable psychoactive effect to LSD.
In the case of prodrugs of LSD and LSD analogues, it has not been conclusively clarified whether, in addition to their psychoactive effect, they can produce other pharmacological effects. How potent these prodrugs are compared to the resulting substance (e.g., 1P-LSD to LSD), and to what extent a delay in onset of action occurs in each case, may be substance-dependent and cannot be generalized. Therefore, it is important to approach the dose/effect carefully to avoid overdoses.
If you or someone else needs urgent help after taking drugs or alcohol, call an ambulance on 144. Tell the emergency responders everything you know.
It could save lives.